Perspective Therapeutics, Inc. financial data

Symbol
CATX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
2401 Elliott Avenue, Suite 320, Seattle, WA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
IsoRay, Inc. (to 2/16/2023), Isoray, Inc. (to 2/16/2023), CENTURY PARK PICTURES CORP (to 8/3/2005)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.07K % +33.4%
Quick Ratio 18.2 % -64.6%
Debt-to-equity 17.2 % +97.8%
Return On Equity -31.7 % -42.8%
Return On Assets -27.1 % -32.5%
Operating Margin -93.7 % -91.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.4M shares -76%
Common Stock, Shares, Outstanding 67.4M shares -76%
Entity Public Float 186M USD +328%
Common Stock, Value, Issued 67K USD -76.1%
Weighted Average Number of Shares Outstanding, Basic 66.6M shares +138%
Weighted Average Number of Shares Outstanding, Diluted 66.6M shares +138%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.19M USD +27.3%
Research and Development Expense 29.4M USD +257%
Selling and Marketing Expense 855K USD +6.88%
General and Administrative Expense 20.8M USD +30.3%
Operating Income (Loss) -48.7M USD -97.1%
Nonoperating Income (Expense) 4.44M USD +275%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -44.3M USD -88.2%
Income Tax Expense (Benefit) -2.65M USD
Net Income (Loss) Attributable to Parent -59M USD -214%
Earnings Per Share, Basic 0.03 USD/shares +55%
Earnings Per Share, Diluted -0.18 USD/shares +55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 252M USD +790%
Cash, Cash Equivalents, and Short-term Investments 293M USD
Accounts Receivable, after Allowance for Credit Loss, Current 142K USD -87.2%
Inventory, Net 1.01M USD -34.8%
Other Assets, Current 45K USD
Assets, Current 294M USD +821%
Property, Plant and Equipment, Net 14.7M USD +109%
Operating Lease, Right-of-Use Asset 2.02M USD +151%
Intangible Assets, Net (Excluding Goodwill) 354K USD
Goodwill 24.1M USD -11.9%
Other Assets, Noncurrent 672K USD +17.3%
Assets 386M USD +221%
Employee-related Liabilities, Current 2.31M USD
Liabilities, Current 10.6M USD +23.5%
Deferred Income Tax Liabilities, Net 4.59M USD
Operating Lease, Liability, Noncurrent 1.45M USD +167%
Other Liabilities, Noncurrent 19K USD
Liabilities 44.9M USD +291%
Retained Earnings (Accumulated Deficit) -176M USD -50.3%
Stockholders' Equity Attributable to Parent 341M USD +214%
Liabilities and Equity 386M USD +221%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 13.8M USD
Net Cash Provided by (Used in) Financing Activities 166M USD
Net Cash Provided by (Used in) Investing Activities -47.3M USD -287%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 67.4M shares -76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133M USD +760%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.1M USD -9.13%
Deferred Tax Assets, Valuation Allowance 30M USD +45.4%
Deferred Tax Assets, Gross 38.8M USD +88.6%
Operating Lease, Liability 2.17M USD +170%
Depreciation 346K USD +92.2%
Payments to Acquire Property, Plant, and Equipment 9.07M USD +4413%
Lessee, Operating Lease, Liability, to be Paid 2.44M USD +170%
Property, Plant and Equipment, Gross 16.3M USD +8.27%
Operating Lease, Liability, Current 720K USD +175%
Lessee, Operating Lease, Liability, to be Paid, Year Two 482K USD +51.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 949K USD +197%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 272K USD +178%
Lessee, Operating Lease, Liability, to be Paid, Year Three 320K USD +202%
Deferred Tax Assets, Operating Loss Carryforwards 26.8M USD +39.8%
Preferred Stock, Shares Authorized 7M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 283K USD
Deferred Tax Assets, Net of Valuation Allowance 11K USD
Share-based Payment Arrangement, Expense 2.32M USD -44.1%
Interest Expense 84 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%